We also show a concomitant increase in pSTAT6 in the proliferating ZAP70+ CLL cells, suggesting that signaling downstream of the IL-4R could participate in CLL proliferation, which reinforces the need to evaluate therapeutic agents inhibiting this pathway39,47. Here, IL4R is linked to B-cell chronic lymphocytic leukemia.